Afya Limited
NASDAQ:AFYAEducation & Training Services
-$0.26 today
- Market cap
- $941.96M
- Beta
- 0.36
- P/E (TTM)
- 8.3
- EPS (TTM)
- $8.45
- Dividend yield
- 4.84%
Volume 0.13M
Average 0.10M
AFYA Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Afya LimitedNASDAQ: AFYA
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was R$0, compared with R$0 a year earlier. Trailing-twelve-month research & development was R$0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, down 0.6 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near R$0 or moves back toward the trailing-twelve-month quarterly average of R$0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
BRL · from the income statement
- Latest · FY2025
- 0 BRL
- Year-over-year change
- -100.0%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 20.09M | -6.6% |
| FY2023 | 2023-12-31 | 21.5M | +127.9% |
| FY2022 | 2022-12-31 | 9.44M | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How AFYA compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -100.0% is the lowest of 2, against a peer median of +7.4%.
- Research & development amounts to 0.0% of revenue for AFYA, versus a peer median of 8.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $52.54M USD | +7.4% | +4.8% | 16.9% | |
| LTM Mar 2026 | R$0 BRL | -100.0% | — | 0.0% | |
| LTM Jul 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding AFYA) | — | +7.4% | +4.8% | 8.4% | |
Competitors are the stored peer set for AFYA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.72B | 2.33B | 2.88B | 3.3B | 3.62B |
| Cost of Revenue | 652.3M | 859.55M | 1.11B | 1.22B | 1.29B |
| Gross Profit | 1.07B | 1.47B | 1.77B | 2.09B | 2.34B |
| Gross Margin | 62.1% | 63.1% | 61.4% | 63.2% | 64.5% |
| Research & Development | 0 | 9.44M | 21.5M | 20.09M | 0 |
| Selling, General & Admin | 622.62M | 798.15M | 1.01B | 1.07B | 1.15B |
| Operating Expenses | 626.18M | 805.58M | 999.04M | 1.08B | 1.15B |
| Depreciation & Amortization | 154.22M | 211.94M | 289.51M | 204.12M | 0 |
| EBITDA | 603.33M | 929.03M | 1.11B | 1.22B | 1.34B |
| EBITDA Margin | 35.1% | 39.9% | 38.4% | 36.9% | 36.9% |
| Operating Income | 440.9M | 664.1M | 767.06M | 1.01B | 1.19B |
| Operating Margin | 25.6% | 28.5% | 26.7% | 30.6% | 32.8% |
| Interest Income | 23.04M | 27.2M | 107.12M | 43.42M | 0 |
| Interest Expense | 175.65M | 288.65M | 386.3M | 366.35M | 493.78M |
| Other Income / Expenses | (167.43M) | (235.67M) | (337.48M) | (335.72M) | (345.34M) |
| Income Before Tax | 273.46M | 428.43M | 429.58M | 676.39M | 844.03M |
| Pre-Tax Margin | 15.9% | 18.4% | 14.9% | 20.5% | 23.3% |
| Income Tax Expense | 31.18M | 35.68M | 24.17M | 27.47M | 90.68M |
| Net Income | 223.33M | 373.57M | 386.32M | 631.51M | 737.68M |
| Net Margin | 13.0% | 16.0% | 13.4% | 19.1% | 20.4% |
| EPS (Basic) | 2.39 | 4.15 | 4.27 | 7.01 | 8.16 |
| EPS (Diluted) | 2.37 | 4.15 | 4.27 | 6.93 | 8.11 |
| Weighted Avg Shares | 93.29M | 89.94M | 90.47M | 90.12M | 90.48M |
| Weighted Avg Shares (Diluted) | 94.1M | 89.94M | 90.54M | 91.15M | 91.27M |
Afya Limited
NASDAQ:AFYA
Intrinsic Alpha fair value
Locked
Current Price
$10.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.